Long-Term Trends In Acute Bronchodilator Responses Over 4 Years In Patients With Mild/moderate To Very Severe COPD: Post-Hoc Analysis Of Data From The Uplift Trial

被引：0
|
作者：
Tashkin, D. P. [1 ]
Li, N. [1 ]
Kleerup, E. [1 ]
Halpin, D. [2 ]
Decramer, M. [3 ]
Celli, B. R. [4 ]
Elashoff, R. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Royal Devon & Exeter Hosp, Exeter, Devon, England
[3] Univ Leuven, Leuven, Belgium
[4] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5974
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD
    Donald P Tashkin
    Ning Li
    Eric C Kleerup
    David Halpin
    Bartolome Celli
    Marc Decramer
    Robert Elashoff
    Respiratory Research, 15
  • [2] Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD
    Tashkin, Donald P.
    Li, Ning
    Kleerup, Eric C.
    Halpin, David
    Celli, Bartolome
    Decramer, Marc
    Elashoff, Robert
    RESPIRATORY RESEARCH, 2014, 15
  • [3] SHORT-TERM CLINICALLY IMPORTANT DETERIORATION PREDICTS LONG-TERM CLINICAL OUTCOME IN COPD PATIENTS: A POST-HOC ANALYSIS OF THE TORCH TRIAL
    Naya, I.
    Tombs, L.
    Jones, P.
    THORAX, 2015, 70 : A34 - A35
  • [4] Effects Of Tiotropium On Exacerbations In Patients With COPD With Low Or High Risk Of Exacerbations: A Post-Hoc Analysis From The 4-Year Uplift® Trial
    Celli, B. R.
    Asijee, G.
    Kupas, K.
    Decramer, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [5] Effects of Tiotropium on Exacerbations in Patients with COPD with Low or High Risk of Exacerbations: A Post-Hoc Analysis from the 4-Year UPLIFT (R) Trial
    Celli, Bartolome R.
    Decramer, Marc
    Asijee, Guus M.
    Kupas, Katrin
    Tashkin, Donald P.
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2015, 2 (02): : 122 - 130
  • [6] LONG-TERM REMISSION AND OUTCOMES IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA RECEIVING BENRALIZUMAB: MELTEMI POST-HOC ANALYSIS
    Bourdin, Arnaud
    Shavit, Anat
    Swisher, Sean
    Cohen, David
    Korn, Stephanie
    CHEST, 2024, 166 (04) : 57A - 57A
  • [7] Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD
    Tashkin, Donald P.
    Li, Ning
    Halpin, David
    Kleerup, Eric
    Decramer, Marc
    Celli, Bartolome
    Elashoff, Robert
    RESPIRATORY MEDICINE, 2013, 107 (12) : 1904 - 1911
  • [8] A post-hoc subgroup analysis of data from a six month clinical trial comparing the efficacy and safety of losmapimod in moderate-severe COPD patients with ≤ 2% and > 2% blood eosinophils
    Marks-Konczalik, Joanna
    Costa, Maria
    Robertson, Jon
    Mckie, Elizabeth
    Yang, Shuying
    Pascoe, Steven
    RESPIRATORY MEDICINE, 2015, 109 (07) : 860 - 869
  • [9] Long-term safety of risankizumab in patients with moderate to severe psoriasis: Analysis of pooled clinical trial data
    Leonardi, Craig
    Bachelez, Herve
    Wu, Jashin J.
    Sinvhal, Ranjeeta
    Valdes, Joaquin
    Waterhouse, Brian
    Valdecantos, Wendell C.
    Lebwohl, Mark
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB234 - AB234
  • [10] Comparison Of The Annual Rates Of Change In Fev1 And FVC Determined From Serial Measurements Of The Pre- Vs. Post-Bronchodilator Fev1 And FVC Over 4 Years In Moderate Yo Very Severe COPD: Results From The Uplift Trial
    Tashkin, D. P.
    Li, N.
    Halpin, D.
    Kleerup, E.
    Decramer, M.
    Celli, B. R.
    Elashoff, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
12345